Literature DB >> 19114598

Deiodination and cellular proliferation: parallels between development, differentiation, tumorigenesis, and now regeneration.

Stephen A Huang1.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19114598      PMCID: PMC2630899          DOI: 10.1210/en.2008-1460

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  20 in total

1.  Asymmetric growth and development of the Xenopus laevis retina during metamorphosis is controlled by type III deiodinase.

Authors:  N Marsh-Armstrong; H Huang; B F Remo; T T Liu; D D Brown
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

2.  Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas.

Authors:  S A Huang; H M Tu; J W Harney; M Venihaki; A J Butte; H P Kozakewich; S J Fishman; P R Larsen
Journal:  N Engl J Med       Date:  2000-07-20       Impact factor: 91.245

3.  Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium.

Authors:  Stephen A Huang; David M Dorfman; David R Genest; Domenico Salvatore; P Reed Larsen
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

4.  The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate.

Authors:  Monica Dentice; Amitabha Bandyopadhyay; Balázs Gereben; Isabelle Callebaut; Marcelo A Christoffolete; Brian W Kim; Sahar Nissim; Jean-Paul Mornon; Ann Marie Zavacki; Anikó Zeöld; Luciane P Capelo; Cyntia Curcio-Morelli; Rogério Ribeiro; John W Harney; Clifford J Tabin; Antonio C Bianco
Journal:  Nat Cell Biol       Date:  2005-06-19       Impact factor: 28.824

5.  Induction of type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system.

Authors:  W W Li; C Le Goascogne; M Ramaugé; M Schumacher; M Pierre; F Courtin
Journal:  Endocrinology       Date:  2001-12       Impact factor: 4.736

6.  Ontogeny of iodothyronine deiodinases in human liver.

Authors:  K Richard; R Hume; E Kaptein; J P Sanders; H van Toor; W W De Herder; J C den Hollander; E P Krenning; T J Visser
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

7.  Large induction of type III deiodinase expression after partial hepatectomy in the regenerating mouse and rat liver.

Authors:  Monique H A Kester; Mathilda J M Toussaint; Carine A Punt; Ramadan Matondo; Anne M Aarnio; Veerle M Darras; Marjanne E Everts; Alain de Bruin; Theo J Visser
Journal:  Endocrinology       Date:  2008-09-11       Impact factor: 4.736

8.  Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure.

Authors:  Frank W J S Wassen; Anja E Schiel; George G J M Kuiper; Ellen Kaptein; Onno Bakker; Theo J Visser; Warner S Simonides
Journal:  Endocrinology       Date:  2002-07       Impact factor: 4.736

9.  Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours.

Authors:  L A Tannahill; T J Visser; C J McCabe; S Kachilele; K Boelaert; M C Sheppard; J A Franklyn; N J L Gittoes
Journal:  Clin Endocrinol (Oxf)       Date:  2002-06       Impact factor: 3.478

10.  Thyroxine 5-deiodinase in human brain tumors.

Authors:  K Mori; K Yoshida; T Kayama; N Kaise; H Fukazawa; Y Kiso; K Kikuchi; Y Aizawa; K Abe
Journal:  J Clin Endocrinol Metab       Date:  1993-11       Impact factor: 5.958

View more
  4 in total

Review 1.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

2.  Using whole mount in situ hybridization to examine thyroid hormone deiodinase expression in embryonic and larval zebrafish: a tool for examining OH-BDE toxicity to early life stages.

Authors:  Wu Dong; Laura J Macaulay; Kevin W H Kwok; David E Hinton; Heather M Stapleton
Journal:  Aquat Toxicol       Date:  2013-03-04       Impact factor: 4.964

3.  Mice with hepatocyte-specific deficiency of type 3 deiodinase have intact liver regeneration and accelerated recovery from nonthyroidal illness after toxin-induced hepatonecrosis.

Authors:  Luciana A Castroneves; Rebecca H Jugo; Michelle A Maynard; Jennifer S Lee; Ari J Wassner; David Dorfman; Roderick T Bronson; Chinweike Ukomadu; Agoston T Agoston; Lai Ding; Cristina Luongo; Cuicui Guo; Huaidong Song; Valeriy Demchev; Nicholas Y Lee; Henry A Feldman; Kristen R Vella; Roy W Peake; Christina Hartigan; Mark D Kellogg; Anal Desai; Domenico Salvatore; Monica Dentice; Stephen A Huang
Journal:  Endocrinology       Date:  2014-07-08       Impact factor: 4.736

4.  The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration.

Authors:  Monica Dentice; Alessandro Marsili; Raffaele Ambrosio; Ombretta Guardiola; Annarita Sibilio; Ji-Hye Paik; Gabriella Minchiotti; Ronald A DePinho; Gianfranco Fenzi; P Reed Larsen; Domenico Salvatore
Journal:  J Clin Invest       Date:  2010-10-11       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.